The minimum number of lymph node retrieval in gastric cancer patients after neoadjuvant therapy: An international multi-institute cohort study

  • 0Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China; Key Laboratory of Gastrointestinal Cancer (Fujian Medical University), Ministry of Education, Fuzhou, China.

|

|

Summary

This summary is machine-generated.

For gastric cancer patients receiving neoadjuvant therapy, retrieving at least 24 lymph nodes is crucial. This threshold improves survival prediction and reduces stage migration, enhancing prognostic accuracy after gastrectomy.

Area Of Science

  • Oncology
  • Surgical Oncology
  • Gastrointestinal Cancer Research

Background

  • The optimal number of lymph nodes to retrieve after neoadjuvant therapy for gastric cancer is debated.
  • Accurate staging and prognosis are essential for guiding treatment decisions.

Purpose Of The Study

  • To establish the minimum lymph node retrieval threshold for accurate staging and prognosis in gastric cancer patients post-neoadjuvant therapy.
  • To investigate the impact of lymph node count on survival outcomes and stage migration.

Main Methods

  • Analysis of clinicopathological data from 2,490 international gastric cancer patients.
  • Multivariate models to assess the correlation between lymph node count, survival, and stage migration.
  • LOWESS smoother and Chow test to identify structural break points in hazard ratio curves.

Main Results

  • A higher number of retrieved lymph nodes correlated with increased detection of positive lymph nodes and improved survival.
  • Cutoff analysis identified 24 retrieved lymph nodes as the minimum threshold.
  • Patients with ≥24 lymph nodes showed significantly better 5-year survival rates and superior predictive performance for survival outcomes.

Conclusions

  • A minimum of 24 retrieved lymph nodes is recommended for evaluating prognosis and reducing stage migration in gastric cancer patients.
  • This threshold aids in more accurate staging and improved patient outcomes after neoadjuvant therapy and gastrectomy.